Institutional investors purchased a net $1.9 million shares of SLXP during the quarter ended March 2014 and now own 104.15% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Pharmaceuticals: Other industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
APEX CAPITAL MANAGEMENT, INC. Bought 134.1 Thousand shares of Salix Pharmaceuticals Ltd